4.6 Article

Construction and validation of a scoring system to predict resistance to chemotherapeutic drugs using gene expression profiles in canine lymphoma

Related references

Note: Only part of the references are listed.
Review Immunology

Positive and Negative Signals in Mast Cell Activation

Silvia Bulfone-Paus et al.

TRENDS IN IMMUNOLOGY (2017)

Review Oncology

Asparaginase pharmacology: challenges still to be faced

Claudia Lanvers-Kaminsky

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

Article Oncology

The dog as a possible animal model for human non-Hodgkin lymphoma: a review

Laura Marconato et al.

HEMATOLOGICAL ONCOLOGY (2013)

Article Pharmacology & Pharmacy

Vascular endothelin receptor type B: Structure, function and dysregulation in vascular disease

Marc Q. Mazzuca et al.

BIOCHEMICAL PHARMACOLOGY (2012)

Article Veterinary Sciences

Quantitative Analysis of m RNA for 10 Different Drug Resistance Factors in Dogs with Lymphoma

Hirotaka Tomiyasu et al.

JOURNAL OF VETERINARY MEDICAL SCIENCE (2010)

Article Hematology

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Gustaf Hedstrom et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Article Oncology

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma

K Jöhrer et al.

CLINICAL CANCER RESEARCH (2005)

Article Biochemistry & Molecular Biology

Mastin is a gelatinolytic mast cell peptidase resembling a mini-proteasome

WW Raymond et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)

Review Cell Biology

Calcitonin

DM Findlay et al.

GROWTH FACTORS (2004)

Review Veterinary Sciences

Mechanisms of anticancer drug resistance

PJ Bergman

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2003)